Jo Singleton
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Genetics top 5%
- Genetic Associations and Epidemiology
Papers in
-
- COVID-19 Clinical Research Studies 9
- SARS-CoV-2 and COVID-19 Research 3
- Genetics 6
- Genetic Associations and Epidemiology 6
- Journals
- JAMA (6 papers)Nature (4 papers)Wellcome Open Research (2 papers)JAMA Network Open (1 paper)Clinical Infectious Diseases (1 paper)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Jo Singleton
18 papers receiving 1.7k citations
Jo Singleton's Hit Papers
Peers
Comparison fields: 5 of 93
- Infectious Diseases 935
- Genetics 520
- Immunology 140
- Neurology 89
- Internal Medicine 18
Countries citing papers authored by Jo Singleton
This map shows the geographic impact of Jo Singleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo Singleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo Singleton more than expected).
Fields of papers citing papers by Jo Singleton
This network shows the impact of papers produced by Jo Singleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo Singleton. The network helps show where Jo Singleton may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 656 |
| 2 | Whole-genome sequencing reveals host factors underlying critical COVID-19 Hit paper breakdown → | 2022 | 233 |
| 3 | 2021 | 166 | |
| 4 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 125 |
| 5 | 2022 | 105 | |
| 6 | 2022 | 100 | |
| 7 | 2021 | 72 | |
| 8 | 2023 | 60 | |
| 9 | 2023 | 46 | |
| 10 | 2024 | 45 | |
| 11 | 2021 | 39 | |
| 12 | 2022 | 34 | |
| 13 | 2023 | 34 | |
| 14 | 2021 | 33 | |
| 15 | 2021 | 26 | |
| 16 | 2021 | 23 | |
| 17 | 2024 | 8 | |
| 18 | 2025 | 1 |
About Jo Singleton
Jo Singleton is a scholar working on Infectious Diseases, Genetics, Immunology, Critical Care and Intensive Care Medicine and Anesthesiology and Pain Medicine, having authored 18 papers that have together received 1.8k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (9 papers), Genetic Associations and Epidemiology (6 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers), Respiratory Support and Mechanisms (2 papers), Erythropoietin and Anemia Treatment (1 paper), Iron Metabolism and Disorders (1 paper) and Anesthesia and Sedative Agents (1 paper). The work is most often cited by research in Infectious Diseases (935 citations), Genetics (520 citations), Immunology (140 citations), Neurology (89 citations) and Internal Medicine (18 citations). Jo Singleton has collaborated with scholars based in United Kingdom, United States and Sweden. Their work appears in journals such as JAMA, Nature, Wellcome Open Research, JAMA Network Open and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.